Metadata record for the manuscript: Effects of systemic inflammation on relapse in early breast cancer

Summary

This metadata record provides details of the
data supporting the claims of the related manuscript: “Effects of systemic
inflammation on relapse in early breast cancer”.

The data consist of a single data spreadsheet
in Stata and open format, and a supporting data dictionary in .txt format.

The related study aimed to assess whether or
not elevated serum inflammatory biomarkers (C-Reactive protein [CRP],
interleukin-6 [IL-6], and serum amyloid A [SAA]) and/or the presence of a
high-risk IL-6 promoter genotype were associated with recurrence of hormone
receptor positive (HR+) early breast cancer.

Data
access

The data generated and/or analysed during the
related study is openly available as part of this metadata record. The data
are as follows:
- WABC
Case Control Deidentified Dataset.xlsx – De-identified dataset for WABC-II Case Control
population with serum and genomic biomarkers as well as outcomes.
- WABC
Case Control Deidentified Dataset.dta – Stata version of the above.
- WABC_data_dictionary.txt – Data dictionary to support the above files.

Name
of Institutional Review Board or ethics committee that approved the study

This study was approved by the Institutional
Review Board of the University of

Pennsylvania and all study procedures were
conducted according to the institution’s code of

ethics.